Positional Pathway Screen of wnt Signaling Genes in Schizophrenia: Association with DKK4

BACKGROUND Wnt signaling has been implicated in schizophrenia from studies of gene expression in patients, from an understanding of the function of reported susceptibility genes and from experimental studies of psychoactive drugs. This diverse evidence suggests that wnt signaling genes, defined as pathway participants, modifiers or targets, are good candidates as susceptibility factors. METHODS We performed a combined positional and candidate association screen by identifying known wnt signaling genes in regions linked to schizophrenia. In a staged study we examined over 50 single nucleotide polymorphisms (SNPs) in 28 wnt signaling genes, first in trios of Chinese origin and then in a case-control series from Hong Kong. RESULTS In both sets, Dickkopf 4 (DKK4) was associated with schizophrenia - with an odds ratio of 3.9 (p < .01, CI = 1.3-11.1) in the combined sample. CONCLUSIONS As DKK family members have previously been found to show altered expression in schizophrenia brain and to bind to neuregulin, this finding suggests that DKK4 may play a role in schizophrenia pathogenesis.

[1]  Chun Li,et al.  Genetic association analysis using data from triads and unrelated subjects. , 2005, American journal of human genetics.

[2]  M. Karayiorgou,et al.  Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia , 2004, Nature Genetics.

[3]  P. Greengard,et al.  Diverse Psychotomimetics Act Through a Common Signaling Pathway , 2003, Science.

[4]  R. Nusse,et al.  Mechanisms of Wnt signaling in development. , 1998, Annual review of cell and developmental biology.

[5]  Stefan Krauss,et al.  Characterisation of the Wnt antagonists and their response to conditionally activated Wnt signalling in the developing mouse forebrain. , 2004, Brain research. Developmental brain research.

[6]  Richard S. J. Frackowiak,et al.  Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. , 2002, The American journal of psychiatry.

[7]  M. Kraus,et al.  Isolation and Biochemical Characterization of the Human Dkk-1 Homologue, a Novel Inhibitor of Mammalian Wnt Signaling* , 1999, The Journal of Biological Chemistry.

[8]  Jeremy Nathans,et al.  Frizzled-3 Is Required for the Development of Major Fiber Tracts in the Rostral CNS , 2002, The Journal of Neuroscience.

[9]  Tao Li,et al.  No association between T102C polymorphism of serotonin-2A receptor gene and clinical phenotypes of Chinese schizophrenic patients , 2001, Psychiatry Research.

[10]  S. Faraone,et al.  Five NOTCH4 polymorphisms show weak evidence for association with schizophrenia: evidence from meta-analyses , 2005, Schizophrenia Research.

[11]  M. First,et al.  The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. , 1992, Archives of general psychiatry.

[12]  Stuart A. Aaronson,et al.  Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow , 2001, Nature Cell Biology.

[13]  S Lovestone,et al.  Abnormalities of Wnt signalling in schizophrenia – evidence for neurodevelopmental abnormality , 1998, Neuroreport.

[14]  N. Rajakumar,et al.  The effects of antipsychotics on β‐catenin, glycogen synthase kinase‐3 and dishevelled in the ventral midbrain of rats , 2005, Journal of neurochemistry.

[15]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[16]  Christof Niehrs,et al.  Mutual antagonism between dickkopf1 and dickkopf2 regulates Wnt/β-catenin signalling , 2000, Current Biology.

[17]  J. Kleinman,et al.  Reduced GSK-3β mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients , 2004, Journal of Neural Transmission.

[18]  Tsuyoshi Miyaoka,et al.  Increased expression of Wnt-1 in schizophrenic brains , 1999, Schizophrenia Research.

[19]  H. Ujike,et al.  The human frizzled-3 (FZD3) gene on chromosome 8p21, a receptor gene for Wnt ligands, is associated with the susceptibility to schizophrenia , 2003, Neuroscience Letters.

[20]  S. Hirsch,et al.  Down‐regulation of Dickkopf 3, a regulator of the Wnt signalling pathway, in elderly schizophrenic subjects , 2005, Journal of neurochemistry.

[21]  M. D. Forti,et al.  Schizophrenia as a GSK-3 dysregulation disorder , 2007, Trends in Neurosciences.

[22]  Robin M. Murray,et al.  A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder , 2004, Schizophrenia Research.

[23]  Vaibhav A. Diwadkar,et al.  Abnormalities in MRI-measured signal intensity in the corpus callosum in schizophrenia , 2004, Schizophrenia Research.

[24]  R. Belmaker,et al.  Low GSK-3 activity in frontal cortex of schizophrenic patients , 2001, Schizophrenia Research.

[25]  C. Crombie,et al.  Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations , 2005, Molecular Psychiatry.

[26]  P. Visscher,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder. , 2003, American journal of human genetics.

[27]  F. Dudbridge.  Pedigree disequilibrium tests for multilocus haplotypes , 2003, Genetic epidemiology.

[28]  R. Nusse,et al.  Wnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors* , 2006, Journal of Biological Chemistry.

[29]  R. Belmaker,et al.  GSK-3 and the neurodevelopmental hypothesis of schizophrenia , 2002, European Neuropsychopharmacology.

[30]  Y. Ahn,et al.  Investigation of genetic association between human Frizzled homolog 3 gene (FZD3) and schizophrenia: Results in a Korean population and evidence from meta-analysis , 2006, Psychiatry Research.